Follow-up studies should analyse how other tumor cell lines act following 213Bi-anti-EGFR-MAb treatment with regard to [18F]FDG-uptake and pyruvate conversion as well as in vivo studies as this data only represents in vitro observations and can only transferred to in vivo situations with precaution. Here, EGFR is linked to neoplasm.